Elevance Health Inc.

Elevance Health Inc.

ELVNYSEHealthcare
$428.26
down -0.17 (-0.04%)

1-Year Price

+28.74% past year
Elevance Health Inc. (ELV) 1-year price chart: up 28.74% from $332.66 on Oct 2025 to $428.26 on Oct 2026. Closing range $280.74 to $428.43.

EquityGlimpse Score

Overall
5.6/10
Narrow Moat

Some competitive advantages, though less durable than a wide moat.

Growth
4
Sign up free to see the full breakdown

Valuation, profitability, financial health, dividend and sentiment scores for Elevance Health Inc. (ELV) are available to EquityGlimpse members.

Market Cap
92.88B
P/E Ratio
13.92
EPS
$25.53
52W High
$436.24
52W Low
$274.84
Volume
1.21M
Beta
0.71
Dividend Yield
1.97%
Fair value estimate: sign up to see
Is ELV over- or undervalued? Run DCF and multiples models on EquityGlimpse.
See fair value

Key Financial Metrics

Price to Sales
0.39
Price to Book
1.77
EV/EBITDA
10.51
Free CF per Share
$14.31
Op. CF per Share
$19.34
Debt to Equity
0.76
Gross Margin
25.56%
Net Margin
2.84%

About Elevance Health Inc.

Operating as a major health benefits organization, Elevance Health Inc. commits to guiding consumers, families, and communities across their entire health and wellness path. It facilitates access to vital care, assistance, and tools designed to enable healthier living for approximately 118 million individuals. The company's comprehensive offerings span medical, digital, pharmaceutical, behavioral health, clinical, and other care solutions. Founded in 1944 and based in Indianapolis, Indiana, this entity adopted its current name, Elevance Health Inc., in June 2022, having previously operated as Anthem, Inc.

CEO
Gail Koziara Boudreaux
Industry
Medical - Healthcare Plans
Employees
96,615
IPO Date
2001-10-30
Country
US
Website
elevancehealth.com
Unlock Full Analysis

Get the complete picture on Elevance Health Inc.

Sign up for EquityGlimpse to access deep fundamental data, AI reports, valuation models, and real-time tracking for ELV and 8,500+ other stocks.

30 Years of Financials
Income statements, balance sheets, and cash flows with 70+ interactive charts
AI-Powered Analysis
Generate professional research reports with 15+ AI models
DCF Valuation
Run discounted cash flow models with customizable assumptions
Portfolio Tracking
Track real-time P&L, sector allocation, and dividend projections
Earnings Intelligence
Surprise tracking, revision momentum, and whisper estimates
Insider & Congress Trades
Monitor what insiders and Congress members are buying and selling
Start 7-Day Free Trial View Pricing

Starting at $8.25/month. 7-day free trial. Cancel anytime.